MRVAC (The Centre for Research and Production of Vaccines and Biologicals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMRVAC (The Centre for Research and Production of Vaccines and Biologicals)
Drug Alias NameMRVACAIK-C measles/Takahashi rubella virus strain combined vaccine
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMeasles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRubellaMeasles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A